Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 18,502 | 27,837 | 44,335 | 115,796 | 51,387 |
| Operating Income | -18,502 | -27,837 | -44,335 | -115,796 | -51,387 |
| Interest Expense | 230 | 120 | 0 | 18 | 56 |
| Other Income | -6,394 | -2,193 | 4,581 | 22,751 | -334 |
| Pre-tax Income | -25,126 | -30,150 | -39,754 | -93,063 | -51,777 |
| Net Income Continuous | -25,126 | -30,150 | -39,754 | -93,063 | -51,777 |
| Net Income | $-25,126 | $-30,150 | $-39,754 | $-93,063 | $-51,777 |
| EPS Basic Total Ops | -2.36 | -3.98 | -6.00 | -74.40 | -15.10 |
| EPS Basic Continuous Ops | -2.36 | -3.98 | -6.04 | -19.84 | -15.11 |
| EPS Diluted Total Ops | -2.36 | -3.98 | -6.00 | -74.40 | -15.10 |
| EPS Diluted Continuous Ops | -2.36 | -3.98 | -6.04 | -19.84 | -15.11 |
| EPS Diluted Before Non-Recurring Items | -1.96 | -3.70 | -6.80 | -74.10 | N/A |
| EBITDA(a) | $-18,497 | $-27,832 | $-44,331 | $-115,794 | $-51,368 |